NeoImmuneTech, Inc. (KOSDAQ: 950220)
South Korea
· Delayed Price · Currency is KRW
1,112.00
-14.00 (-1.24%)
Dec 20, 2024, 9:00 AM KST
NeoImmuneTech Company Description
NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics.
It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases.
The company was incorporated in 2014 and is headquartered in Rockville, Maryland.
NeoImmuneTech, Inc.
Country | South Korea |
Founded | 2014 |
Industry | Biological Products, Except Diagnostic Substances |
Employees | 82 |
CEO | Luke Yun Oh |
Contact Details
Address: 2400 Research Blvd. Rockville, 20850 United States | |
Phone | 240 801 9065 |
Website | neoimmunetech.com |
Stock Details
Ticker Symbol | 950220 |
Exchange | KOSDAQ |
Fiscal Year | January - December |
Reporting Currency | KRW |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Luke Yun Oh | Chief Executive Officer |
Tae Woo Kim | Chief Financial Officer |
Goongjin Namgoong | Chief Operating Officer |